LXEO Richard Nolan Townsend sells $454K worth of shares
Jul 12, 2024, 9:34 PM
-2.47%
What does LXEO do
Lexeo Therapeutics Inc, a clinical-stage genetic medicine company based in New York City, went public on November 3, 2023, and employs 53 people. The company develops gene therapy candidates like LX2006 and LX2020 targeting rare cardiovascular diseases with unmet needs.
Richard Nolan Townsend sold 26,969 shares of LXEO on 10 July at $16.85 per share, worth a total of $454K. They now own 152,073 LXEO shares, or a 15% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
